Phathom Pharmaceuticals, Inc. - Common Stock - Nakit Akışı (NASDAQ:PHAT) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -69.69 M-148.62 M-146.53 M-137.58 M-266.77 M-166.78 M -97.49 M Yatırım faaliyetlerinden elde edilen nakit -1.04 M-328 K-1.04 M-1.63 M-135 K-229 K -272 K Finansman faaliyetlerinden elde edilen nakit 114.46 M44.71 M120.04 M367.58 M182.77 M-288 K 66.35 M Serbest nakit akışı -69.69 M-148.62 M-146.53 M-137.58 M-266.77 M-167 M -97.76 M

Haberler

Phathom Pharmaceuticals 1Ç 2026 HBK beklentilerini aştı

Phathom’un 2026 1Ç sunumu: Gelir ikiye katlandı, kârlılık yakın

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Rocket Pharmaceuticals ve Argan seans öncesi yükseldi

Barclays, Phathom Pharmaceuticals hissesini yükseltti

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug